Provinces Warn Ottawa Over CETA IP Provisions

The B.C., Ontario, and Manitoba governments have reportedly expressed concern about the prospect of higher prescription drug prices as a result of the intellectual property provisions in the Canada – EU Trade Agreement.

Tags: / /

One Comment

  1. deliberately adding cost to health care
    is precisely why Canada should not enter into this agreement. Also, the lack of transparency in the deal is troubling. Just whom, other multinational pharmaceutical companies and myopic French farmers, is this agreement benefiting? Why would we enter such a costly agreement especially when both federal and provincial levels of government are running large deficits? The government needs to answer those question directly.